Table 8 Risk of Hypertension in women according to plasma marker quartiles in adjusted models.

From: The relationship between Plasma Markers and Essential Hypertension in Middle-aged and Elderly Chinese Population: A Community Based Cross-sectional Study

Plasma Marker

Plasma markers

Quartile 1

Quartile 2

Quartile 3

Quartile 4

hs-CRP

≤0.53

0.54–1.00

1.01–1.85

≥1.86

Model 1

1.000(ref.)

1.31(0.99–1.75)

1.82(1.36–2.43)‡

1.94(1.45–2.59)‡

Model 2

1.000(ref.)

1.15(0.86–1.54)

1.60(1.19–2.16)†

1.53(1.13–2.08)†

Model 3

1.000(ref.)

1.02(0.75–1.38)

1.26(0.93–1.72)

1.04(0.75–1.45)

Hcy

≤7.55

7.76–8.70

8.71–10.45

≥10.46

Model 1

1.000(ref.)

1.21(0.91–1.61)

1.21(0.91–1.61)

1.53(1.15–2.05)†

Model 2

1.000(ref.)

1.23(0.92–1.64)

1.23(0.92–1.65)

1.53(1.13–2.07)†

Model 3

1.000(ref.)

1.18(0.87–1.59)

1.19(0.88–1.62)

1.39(1.02–1.90)*

hs-TnT

≤5.45

5.46–7.26

7.27–9.42

≥9.43

Model 1

1.000(ref.)

1.26(0.91–1.74)

1.05(0.76–1.45)

1.27(0.92–1.77)

Model 2

1.000(ref.)

1.29(0.92–1.79)

1.04(0.75–1.45)

1.27(0.91–1.78)

Model 3

1.000(ref.)

1.34(0.96–1.88)

1.02(0.73–1.43)

1.18(0.84–1.68)

NT-proBNP

≤35.66

35.67–56.22

56.23–87.06

≥87.07

Model 1

1.000(ref.)

1.11(0.83–1.48)

0.96(0.72–1.27)

1.43(1.07–1.92)*

Model 2

1.000(ref.)

1.22(0.90–1.63)

1.07(0.80–1.44)

1.63(1.20–2.21)†

Model 3

1.000(ref.)

1.29(0.95–1.75)

1.14(0.84–1.54)

1.85(1.35–2.53)‡

25-OHD

≤8.60

8.61–12.30

12.21–16.83

≥16.84

Model 1

1.000(ref.)

0.85(0.64–1.14)

0.77(0.58–1.03)

0.96(0.72–1.28)

Model 2

1.000(ref.)

0.87(0.65–1.17)

0.80(0.59–1.07)

0.95(0.70–1.28)

Model 3

1.000(ref.)

0.84(0.62–1.14)

0.76(0.56–1.03)

0.86(0.63–1.17)

HBA1C (%)

≤4.72

4.73–5.09

5.10–5.11

≥5.12

Model 1

1.000(ref.)

2.45(1.79–3.34)

1.36(1.02–1.81)*

1.01(0.76–1.35)‡

Model 2

1.000(ref.)

1.06(0.80–1.42)

1.34(1.00–1.78)*

2.21(1.61–3.05)‡

Model 3

1.000(ref.)

1.32(0.99–1.74)

1.79(1.33–2.41)‡

2.37(1.70–3.30)‡

Model 4

1.000(ref.)

1.32(1.00–1.75)

1.83(1.36–2.48)‡

2.35(1.63–3.39)‡

Uric Acid

≤243.55

243.56–281.03

281.04–328.26

≥328.27

Model 1

1.000(ref.)

0.96(0.72–1.28)

0.99(0.75–1.32)

1.89(1.41–2.53)‡

Model 2

1.000(ref.)

0.89(0.66–1.19)

0.88(0.65–1.18)

1.56(1.13–2.13)†

Model 3

1.000(ref.)

0.87(0.64–1.17)

0.76(0.56–1.04)

1.20(0.87–1.67)

  1. *P < 0.05; †P < 0.01;‡P < 0.001.
  2. hs-CRP, high-sensitivity C-reactive protein; Hcy, Homocysteine; hs-cTnT, high-sensitivity cardiac troponin T; NT-proBNP, N-terminal prohormone of brain natriuretic peptide; 25OHD, 25-Hydroxyvitamin D; SUA, Serum uric acid; and HbA1c glycosylated hemoglobin A1c.
  3. Model 1: Adjusted for age, cigarette status, Alcohol use, physical activity.
  4. Model 2: Adjusted for the above plus total serum cholesterol, high-density lipoprotein, LDL-C, triglycerides, and creatinine.
  5. Model 3: Adjusted for the above plus BMI and Diabetes Mellitus.
  6. Model 4: Sensitivity analysis for HBA1c.
Back to article page